Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy-Reference-Cited by-同舟云学术

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

Published:2016-04-11 Issue:8 Volume:51 Page:1156-1158
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gonsalves W I,Rajkumar S V,Gertz M A,Dispenzieri A,Lacy M Q,Buadi F K,Dingli D,Go R S,Leung N,Kapoor P,Hayman S R,Lust J A,Russell S J,Zeldenrust S R,Hwa Y L,Kourelis T V,Kyle R A,Kumar S K

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201691.pdf

Reference15 articles.

1. Martinez-Lopez J, Blade J, Mateos MV, Grande C, Alegre A, Garcia-Larana J et al. Long-term prognostic significance of response in multiple myeloma after stem cell transplantation. Blood 2011; 118: 529–534.

2. Kapoor P, Kumar SK, Dispenzieri A, Lacy MQ, Buadi F, Dingli D et al. Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma. J Clin Oncol 2013; 31: 4529–4535.

3. Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K et al. International uniform response criteria for multiple myeloma. Leukemia 2006; 20: 1467–1473.

4. Kumar S, Mahmood ST, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK et al. Impact of early relapse after auto-SCT for multiple myeloma. Bone Marrow Transplant 2008; 42: 413–420.

5. Fernandez de Larrea C, Jimenez R, Rosinol L, Gine E, Tovar N, Cibeira MT et al. Pattern of relapse and progression after autologous SCT as upfront treatment for multiple myeloma. Bone Marrow Transplant 2014; 49: 223–227.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to progression predicts outcome of myeloma patients that can be influenced by autologous hematopoietic stem cell transplantation;2024-02-27

2. Subcutaneous injection of a bortezomib-loaded thermosensitive hydrogel for the treatment of multiple myeloma;Chemical Engineering Journal;2023-01

3. Liposomal Melphalan: Approach to obtain improved plasma stability, pharmacokinetics, and in vitro and in vivo anticancer efficacy in combination with liposomal simvastatin against mouse RPMI-8226 multiple myeloma model;Journal of Drug Delivery Science and Technology;2022-07

4. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center;Clinical Lymphoma Myeloma and Leukemia;2021-07

5. Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma;Nature Communications;2020-11-27